mssny helix
mssny helix mssny helix
mssny helix
mssny helix mssny helix
Search  mssny helix
MSSNY - enews060112
MSSNY Member Login
mssny spacer
mssny spacer
mssny spacer
»
mssny spacer mssny spacer
mssny spacer »
mssny spacer
mssny spacer
mssny spacer
mssny spacer
mssny spacer
mssny spacer
mssny spacer
mssny spacer
mssny spacer
medical society


          President, Bob Hughes, MD

June 1, 2012
Weekly Update for New York State Physicians
Volume 12, Number 20
Christina Cronin Southard, Editor
mssnye-news@mssny.org www.mssny.org

 

 

 

Blog Question of the Week

This week, NYC Mayor Michael Bloomberg proposed a total prohibition on the sale of sugary beverages ranging from iced tea to sodas in sizes over 16 ounces in restaurants, delis, movie theaters, street carts and sports arenas. Your thoughts?

Click Here to respond to this question. Please Click here if you would like to comment on the introduction Below:

 

 

"Those scornful words "bread and circuses," panem et circenses in Latin, become more meaningful when you understand that Roman citizens became increasingly addicted to free distributions of food, and the violent gladiatorial contests held in the Coliseum and the chariot races of the Circus Maximus. Juvenal, the Roman satirist, felt that Romans had lost the capacity to govern themselves so distracted by mindless self-gratification had they become. Thus, “bread and circuses,” is now a phrase used to deplore a population so distracted with entertainment and personal pleasures (sometimes by design of those in power) that they no longer value the civic virtues and bow to civil authority with unquestioned obedience. Bread and circuses has also become a general term for government policies that seek short-term solutions to public unrest.

These sentiments hold a particular relevance to our profession now. We all know the problem of insurers trying to determine patient care rather than the physicians
judgments. We all know the problem of well-meaning, but short-sighted legislative
proposals that seek to impose standards of care upon physicians that in fact often get in way of providing fair and quality care.

Two Incidents
Two developments occurred over the last few weeks that have exacerbated my
concerns regarding societal efforts to take away our role as the chief advocate for our patients. The first was a report issued by the Institute of Medicine (IOM),” The Future of Nursing: Leading Change, Advancing Health,” which suggested expanding the already broad scope of the Federal Trade Commission (FTC) to “review existing and proposed state regulations concerning APRNs to identify those that have anticompetitive effects
.

The second was a conclusion by the United State Preventative Services Task Force
recommending against PSA tests for prostate cancer. (See press release below.) These are the same folks who last year recommended against ordering of mammograms for women under the age of 50.

Who Will Decide?
And so we must continue to ask ourselves: Who are we going to let decide the
standards of care? The insurance companies or us? The government or us? We must
make a stand to assure that we are the ones who remain the chief advocates for our patients. If we abdicate this role, others out there are happy to fill the void.
There is a solution to the problems we face. Join MSSNY and your county medical
society so that we have the necessary resources to fight these fights in our State
Capitol and the halls of Congress. Join MSSNYPAC so that we can effectively
participate in the political process to elect leaders who are responsive to our concerns.

Call your legislators to let them know of concerns with various pieces of legislation and support for critically needed reforms. Become active within your specialty society to assure guidelines are determined by physicians with appropriate expertise. And
encourage all of your colleagues to do the same.

Be a leader. Advocate for your profession. Let’s work together to protect our ability to provide the care our patients depend upon.

Dr. Robert J. Hughes, MD, FACP

 

 



Colleagues:

...] iam pridem, ex quo suffragia nulli / uendimus, effudit curas; nam qui dabat olim /imperium, fasces, legiones, omnia, nunc se / continet atque duas tantum res anxius optat, / panem et circenses. [...] (Juvenal, Satire 10.77–81)

("The people that once bestowed commands, consulships, legions, and all else, now
meddle no more and longs eagerly for just two things — bread and circuses.")

         


PLEASE URGE YOUR LEGISLATORS TO SUPPORT OUT-OF-NETWORK TRANSPARENCY LEGISLATION
With just three weeks left in the legislative session, all physicians must continue to call, write, and fax their legislators and Governor  Cuomo’s office to express support for legislation (A.7489-B, Gottfried/S.5068-A, Hannon) to assure patients and employers are better informed regarding the scope of their health insurance coverage for out-of-network care.  Aggressive health insurer opposition, as well as opposition from some business groups, is slowing down consideration of this measure, so your advocacy is absolutely essential for this measure to be enacted. 

This bill would: (a) prevent insurance companies from selling policies with out-of-network coverage that fail to provide significant coverage for such costs; and (b) better assure transparency of health insurance policies that provide out-of-network coverage by requiring all such policies to expressly state the percentage of the likely actual costs of care (as reported in the FAIR Health database) it will cover.  Many companies are now defining their out-of-network coverage as a percentage of the Medicare fee schedule, which deceptively gives consumers the impression that their policies cover the ability to see the physician of their choice when in fact these policies often barely cover any health care costs.  


MSSNY continues to meet with key leaders in the Assembly, Senate, and Cuomo administration to urge the enactment of this or legislation incorporating similar concepts. Moreover, MSSNY has been working closely with several patient advocacy groups to coordinate action in support of addressing this problem. 


To assist physicians in their grassroots advocacy, MSSNY has also created a new section on its website that includes talking points, MSSNY’s memo in support of this legislation, a patient educational flier, a template script for physicians and patients to follow in calling their legislators, recent news articles in the New York Times and New York Daily News detailing this problem, and a link  to send a letter to your legislators from MSSNY’s Grassroots Action Center in support of this legislation:

Please act today!            
(AUSTER, DEARS, CONWAY)

COLLECTIVE NEGOTIATION BILL—NEEDS PHYSICIAN ADVOCACY
With only eleven session days remaining in the legislative session, physician advocacy is requested in support of legislation (A.2474-A, Canestrari/S. 3186-A, Hannon) which would permit independently practicing physicians to negotiate collectively with health insurance companies.  This legislation, which now has 67 co-sponsors, has advanced from the Assembly Health Committee to the Assembly Ways and Means Committee but has failed to advance further in that house.  Identical legislation (S.3186-A, Hannon) is back before the Senate Health Committee after having passed the Senate last year, but it hasn’t yet moved this year.

Collective action by independently practicing physicians is now prohibited under federal antitrust laws. 

As a result, with most regions of New York State being dominated by just one or two health plans, most physicians face one-sided contracts from health insurers with little if any opportunity to negotiate.   It is the patient, however, who bears the brunt of this market dynamic, because the physicians’ inability to negotiate results in the imposition of unnecessary barriers for patients as they seek to access necessary care.  These health plan abuses include: cumbersome pre-authorization processes that delay our patients from receiving needed care and testing; arbitrary limitations on necessary prescription medications; and overly aggressive barriers that limit patients’ ability to receive care from the specialist physician of their choice.

An all-out grass roots push is necessary because the health insurance industry is doing all in its power to stop this measure from going forward.  If you want to level the playing field with the health insurers, please make these contacts!

All physicians are urged to contact their legislators in support of this critically needed legislation, and can send a letter to their legislators in support of this legislation by clicking here.
(DEARS, AUSTER, CONWAY)

MSSNY PARTICIPATES IN THE ONGOING NEGOTIATIONS ON PRESCRIPTION DRUG ABUSE AND DIVERSION ISSUE
The Medical Society of the State of New York’s leadership and staff continue to meet with various members of the legislature and the governor’s office to discuss issues pertaining to the prescription drug abuse and diversion issues.  Negotiation continues regarding the extent of a potential duty on the physician to check a database prior to prescribing a controlled substance.  Negotiations also continue regarding who can check the database on behalf of the physician.  MSSNY leadership has indicated that the medical profession wants to be part of the solution; however, it wants to ensure that any law that is adopted does not create obstacles that unintentionally interfere with patients’ ability to obtain necessary pain medication.  It is anticipated that the negotiations will result in legislation that will be enacted before the legislature adjourns for the year.

There is already legislation, such as the I-STOP legislation (A.8320/S.5720A) which would require physicians or their staff to check the database prior to writing of any controlled substance prescription and enter the prescription information into the database.  Significant penalties would be imposed for failure to comply.  MSSNY believes that this type of legislation could cause significant delays in patients receiving necessary pain medications.  Physicians are urged to weigh in against this bill and to contact their legislators about this issue as bills such as this could cause patients to encounter significant delays in receiving their pain medication. To contact your senator, call (518) 455-2800; call your assemblymember at (518) 455-4100.  Or you can use the MSSNY Grassroots Action Center to send a letter to legislators expressing opposition the I-STOP legislation.

The Medical Society of the State of New York; 18 state medical specialties, and various patient-advocacy organizations; the Leukemia & Lymphoma Society; Lupus Foundation of Mid and Northern New York, Inc.; Lupus Alliance of America; NY Southern Tier Affiliate; the Epilepsy Foundation of Northeastern NY; the International Institute of Human Empowerment; and the US Pain Foundation have joined together in the issuance of a statement entitled “Recommendations to Address the Prescription Drug Abuse and Diversion Issue.”   Key recommendations include:  increased law enforcement efforts to prevent and punish inappropriate diversion of prescription medications;  the need for increased accessibility to treatment for patients suffering addictions so as to reduce the likelihood of inappropriate diversion of prescribed medications;  improvement in and better use of the existing database that is currently maintained by the New York State Health Department on all controlled substance prescriptions; and the need for additional resources for associations representing prescribers so that they can educate their members about the existence of the database and the characteristics of patients presenting themselves in health care settings that should trigger a prescriber to check the database.  

For more information, contact Pat Clancy at pclancy@mssny.org; Liz Dears at ldears@mssny.org; Moe Auster at mauster@mssny.org; or Gerry Conway at gconway@mssny.org.
(CLANCY, DEARS, AUSTER, CONWAY)


LEGISLATION TO PERMIT RETAIL CLINICS IN NEW YORK ON SENATE HEALTH COMMITTEE AGENDA
Legislation (S.3673B, Hannon) which would permit publicly traded corporations to operate diagnostic or treatment centers through which health care services may be provided within a retail business, including but not limited to a pharmacy, a store open to the general public, or a shopping mall, will be considered by the Senate Health Committee next week. MSSNY opposes this bill, which provides a mechanism to avoid existing public health law prohibitions that prevent publicly traded corporations from owning certain facilities through which health care is provided.  A similar exception was utilized a few years ago, but in that instance, it was permitted to enable a discrete, definable outpatient service (renal dialysis) to continue to be offered in NYS because all other financial support (mostly federal financial support) had dissipated. 

To the contrary, in this instance with retail clinics, the types of services sought to be performed in such clinics are broad, and the applicable treatments to be prescribed vary significantly.  Moreover, the type of service(s) sought to be provided derive from an ever expanding list of diagnoses.  While the service(s) sought to be delivered may be covered by Medicare, they may also be covered through commercial insurance and Medicaid, CHP, and FHP.  Lastly, there already exist a vast health care workforce of physicians and allied health professionals to service the health care needs of the state’s residents.

In addition, MSSNY also argues that allowing retail clinics in New York was diametrically opposite to the direction taken in the recently enacted budget toward enabling models for integrated care coordination such as the patient centered medical home, accountable care organization and behavioral health organization.

Some policymakers have inquired as to how the public’s interest in coordinated quality health care is better served in a Duane Reade-like model where a physician rented space, employed or collaborated with NPs, and employed PAs to deliver care than under the “Minute Clinic” model where NPs employed by a clinic owned by a for-profit corporation provide care for certain acute illnesses (sore throats or flu). MSSNY has noted that under the Duane Reade-like model, the physician is in no way beholden to the bottom line of the company from whom he rents space.  The NP in the Minute Clinic, however, may be facing intense pressure to assure that the company profits from the delivery of health care in that setting.  Most importantly, however, MSSNY stated that we like neither option.  Each provides only episodic patient care and only for certain conditions. 

Each model diverges from the medical home model in significant ways, the most significant of which is that the PCMH model emphasizes comprehensive care which is coordinated in an integrated way across all providers and for all patients, even those with more complex and chronic illnesses.  Significantly, in 2008, more than twenty physician groups or hospital chains operated retail clinics, including Mayo Clinic and Geisinger Health Systems.  Each retail clinic is linked to (a) primary care practice(s).  In this integrated model, the retail clinic is the extension of the patient centered medical home. This type of model would enable the PCMH to offer extended hours and convenience for the patients served by the PCMH.  This model is far preferable to the Minute Clinic model advanced as part of the aforementioned legislation, which merely provides for the establishment of a care delivery structure for episodic care services more commonly provided in urgent care or ER but at a lower price-point.  It is anticipated that if favorably reported, the bill will be referred to the Senate Finance Committee.

Physicians are urged to contact their state senator to voice their objection to this measure by calling the Senate switchboard at 518-455-2800 and ask that your call be directed to your state senator’s office.
(DEARS, AUSTER, CONWAY)

EXPEDITED PRESCRIPTION DRUG PRIOR AUTHORIZATION LEGISLATION ADVANCES 
The Assembly Health Committee unanimously reported to the Assembly Ways and Means committee this week legislation (A.10248-A, P. Rivera) supported by MSSNY that would hasten and standardize the process for review by health plans of requests for coverage of prescription medications for patients.  This legislation would enact a number of important reforms to expedite the utilization review process for prescription medications for patients, and reduce the administrative burden on physicians and their staff requesting coverage for particular medications including:

o Reducing the time frames within which a health plan must respond to a request for authorization for a particular prescription medication;

o Treating a failure by a health plan to respond to a request for authorization for a medication as an approval for coverage (under current law, failure to respond by a health plan is treated as an “adverse determination,” requiring a physician to make a further appeal); and

o Requiring the creation and use of a uniform form for obtaining prior authorization for prescription drug benefits.

MSSNY is working to find a sponsor in the Senate for this legislation.  
(AUSTER, DEARS)

 

PHYSICIANS URGED TO RETURN EXCESS APPLICATION AND ADDENDUM TO THEIR SECTION 18 CARRIERS
By now, physicians should have received provisional renewal notices from their Excess liability (Section 18) carriers asking them to complete the application and addendum and return it by June 1, 2012 in order to bind coverage for the next policy period beginning on July 1.  Completion of the addendum is necessary to assist the Superintendent of Financial Services and Commissioner of Health in the completion of a report required by the recently enacted budget which will review the nature and  extent  of  affiliations  between  physicians, dentists,  general hospitals, private practices, and universities and conduct an actuarial analysis concerning the adequacy of premiums paid for the Excess coverage. It must be noted that the question on the questionnaire inquiring as to whether a physician has rendered emergency medical services at the primary affiliated general hospital within the past twelve months does not accurately reflect what state law has required as a condition precedent for eligibility. To be eligible for the Excess program, a hospital must certify to the Commissioner of Health those “physicians who request such certification and who have professional privileges in such hospital and who, from time to time, provide emergency medical or dental care in such hospital to persons who require such care.”  Please consult with your Section 18 carrier if you have not received a provisional renewal notice or have questions concerning the addendum questionnaire.            
(DEARS, AUSTER, CONWAY)

SMOKING NEAR SCHOOL ENTRANCES AND EXITS 
A.19141 (Dinowitz) / S.6854 (Rivera), a bill that would prohibit smoking within one hundred feet of entrances, exits, or outdoor areas of any public or private elementary or secondary schools, was reported to the Codes Committee in the Assembly, and is on the floor of the Senate.  MSSNY has policy that would support policies that eliminate exposure to secondhand smoke in the pediatric population and supports this bill.        
(ELLMAN) 
     

AMA SCOPE-OF-PRACTICE CONFERENCE CALL REGARDING FTC ACTIVITY IN STATES 
The AMA has launched a multi-pronged engagement to combat the FTC examination of state medical board and state legislative actions, particularly those concerning scope of practice.  This action has been taken in the form of letters to a state medical board (Alabama) and state legislators (Florida, Kentucky, Louisiana, Missouri, Tennessee and Texas) commenting on bills to regulate providers of interventional pain management procedures and bills and proposed regulations to expand nursing scope of practice.  The FTC’s activity has also taken the form of an enforcement action against the North Carolina State Board of Dental Examiners, which is on appeal in the US Court of Appeals for the Fourth Circuit.  The AMA has started a multipronged activity including a white paper, which was distributed widely in November of 2011.  The FTC painted what it did as a very minor intrusion.  The AMA wanted them to realize what this would do to the practice of medicine.  The FTC wants to subject state boards to antitrust laws.  If boards have to be subject to antitrust laws and to large fines, with low or no pay, people won’t serve on them.  Twenty-five amicus briefs have been filed so far.                
(ELLMAN) 


MSSNY RE-ACCREDITS 23 ON-LINE COURSES ON EMERGENCY PREPAREDESS; PHYSICIANS ENCOURAGED TO TAKE COURSES
The Medical Society has re-accredited 23 on-line courses on biological, chemical, and nuclear agents and courses on the impact of trauma on mental health.  The Medical Society has accredited these courses with one or two continuing medical education (CME) credits, and the courses are free to physicians throughout the state.  The courses can be accessed here.  Physicians who are new to MSSNY’s CME on-line program will need to register as a new user.  Physicians who already registered may continue to use their log on and password.  

The on-line registration contains instructions on how to view modules and to complete the post-test.  A physician’s name and CME certificate can be printed following the successful completion of the post-test.  The continuing medical education courses on biological, chemical, and nuclear agents curriculum is designed to assist physicians in obtaining experience in bioterrorism preparedness training.  These modules will provide valuable information during any public health emergency involving these agents.  Courses include anthrax, pandemic flu, H1N1, chemical overview, and nuclear radiation.  The mental health curriculum is designed to assist physicians in treating trauma resulting from terrorism and natural disasters.  MSSNY’s Committee on Emergency Preparedness and Disaster/Terrorism has had an instrumental role in providing these programs to New York State physicians.  The program has been funded through a grant from the New York State Department of Health.  Further information on the MSSNY CME website can be obtained by contacting Pat Clancy at pclancy@mssny.org or at 518-465-8085.       
(CLANCY)

 
For more information relating to any of the above articles, please contact the appropriate contributing staff member at the following email addresses: 
  
pschuh@mssny.org
conway@mssny.org ldears@mssny.org mauster@mssny.org pclancy@mssny.org bellman@mssny.org eclinton@mssny.org

 



Press Release: MSSNY Condemns "D" Rating to Life-Saving Prostate Cancer Screening
The Medical Society of the State of New York (MSSNY) joins the American Urological Association (AUA), the Large Urology Group Practice Association (LUGPA) and the American Association of Clinical Urologists (AACU) in condemning the US Preventive Services Task Force (USPSTF) decision to assign a "D" rating to PSA based screening for prostate cancer as ill-advised and irresponsible. The result will be to discourage men from undergoing screening for this potentially fatal and morbid illness.
"One in six men in the United States risks getting prostate cancer during his lifetime. Prostate cancer has always been widespread; however, before 1987, physicians did not screen for it," said Michael M. Ziegelbaum, MD, Vice President of Nassau County Medical Society and a board-certified urologist with Advanced Urology Centers of New York. He added, "At that time 25 percent of men diagnosed with prostate cancer had disease that had spread to other parts of the body, which was inevitably fatal. Today, with early detection, that number has been drastically reduced to less than 5 percent. Overall, the death rate from prostate cancer has decreased by 44 percent in the PSA screening era."

"We are appalled at the USPSTF's recommendation that healthy men should no longer receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening," said Deepak A. Kapoor, MD, President of LUGPA and Chairman and CEO of Integrated Medical Professionals, PLLC. Dr. Kapoor added, "This is a potential public health catastrophe as in five to seven years as those patients we fail to detect early will present with advanced diseases; as a result of this inappropriate recommendation, thousands of men will needlessly die."

The Task Force did not include any urologists or oncologists on its panel and the main study cited – the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial – was seriously flawed. Meanwhile findings of the largest prostate cancer screening trial, European Randomised Study of Screening for Prostate Cancer (ERSPC), which found as much as a 31 percent decrease in cancer-specific mortality in screened vs. non-screened men was discounted by the panel.

The one size fits all downgrade of prostate cancer screening to a "D" recommendation at this time would also deny screening to those at the greatest risk for prostate cancer – African-Americans and those with a family history of prostate cancer. These patients urgently need to be educated about their risks of developing cancer, and the role that screening could play in early diagnosis and treatment.
MSSNY calls on our state legislators to reject this recommendation and to support PSA screening for well-informed men who wish to pursue early diagnosis for a disease that is the second leading cause of cancer death in men. The USPSTF's recommendations risk undoing 20 years of progress in patient education and puts the lives of tens of thousands of men at risk. All concerned citizens are encouraged to contact their State and Federal legislators to demand that access to this life-saving testing is not restricted as a result of these misguided recommendations.
(Sent to all major media outlets)

Specialty Boards Set Time Limits for Certification
In an effort to prevent physicians' indefinite use of the term "board-eligible," all member boards of the American Board of Medical Specialties will limit the time that physicians have to undergo board certification after completing their residencies. Some of the ABMS' 24 member boards already have certification time limits in place; the rest will complete a transition to time limits by Jan. 1, 2019.

According to an ABMS news release, the organization has never recognized the term "board eligible"—a term some physicians use to signal to patients and prospective employers that they intend to seek certification, the release notes. Establishing time limits, according to the release, "makes it legitimate" for physicians to claim eligibility while preventing the term from being abused.

Most of the time limits (PDF) for the 24 boards range between five and seven years. The boards of surgery and thoracic surgery have not yet established time limits. The American Board of Obstetrics and Gynecology has not yet established a starting date for its seven-year limit. Physicians who do not become board-certified within the designated time will have to start the process over and will face sanctions if they continue to describe themselves as "board eligible," according to the release.

"ABMS and its Member Boards believe very strongly that patients, health systems and others who have a stake in high-quality healthcare have a right to know what it means when physicians call themselves 'board-eligible,'" Lloyd Morgan, ABMS interim chief executive, said in the release. "It is a disservice to these stakeholders to allow physicians to use the designation indefinitely without undergoing the rigorous process of board certification."


How to Avoid Common Version 5010 Claims Rejections
 The deadline for the Version 5010 upgrade was January 1, 2012, and the enforcement discretion period for all HIPAA-covered entities to complete their upgrade to the Version 5010 electronic standards ends on June 30, 2012. The Version 5010 transaction standards have different requirements than those of Version 4010 and 4010A. There are a few things to keep in mind for processing your Version 5010 claims, which should help avoid unnecessary rejections:

ZIP Code: You need to include a complete 9-digit ZIP code for the billing provider and service facility location. You should work with your vendor to make sure that your system captures the full 9-digit ZIP. 

Billing Provider Address: You need to use a physical address for your Billing Provider Address. Version 5010 does not allow for use of a PO Box address for either professional or institutional claim formats. You can still use a PO Box, however, as your address for payments and correspondence from payers as long as you report this location as a pay-to address.

National Provider Identifier (NPI): You were previously allowed to report an Employer’s Identification Number (Tax ID) or Social Security Number (SSN) as a primary identifier for the billing provider. For Version 5010 claims, however, you are only allowed to report an NPI as a primary identifier.
 
For additional help with your Version 5010 upgrade and Medicare claims, you can contact your Medicare Administrative Contractor (MAC). If you experience difficulty reaching a MAC, you should send a message describing your issue to ProviderFeedback@cms.hhs.gov with “5010 Extension” in the subject line. The Medicare Fee-For-Service group has created a fact sheet that provides guidance to help providers troubleshoot some of the difficulties they may experience with Version 5010 claims processing and links to each of the MAC websites, including lists of the top 10 edits for Version 5010 claims.
 
Teva’s Adderall 30 mg Tablets: Counterfeit Product - Contains Wrong Active Ingredients
ISSUE: FDA is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets that is being purchased on the Internet. FDA’s preliminary laboratory tests revealed that the counterfeit version of Teva’s Adderall 30 mg tablets contained the wrong active ingredients. Adderall contains four active ingredients – dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate. Instead of these active ingredients, the counterfeit product contained tramadol and acetaminophen, which are ingredients in medicines used to treat acute pain.

BACKGROUND: Adderall, which is approved to treat attention deficit hyperactivity disorders (ADHD) and narcolepsy, is a prescription drug classified as a controlled substance – a class of drugs for which special controls are required for dispensing by pharmacists. The counterfeit Adderall tablets are round, white and do not have any type of markings, such as letters or numbers. Authentic Adderall 30 mg tablets produced by Teva are round, orange/peach, and scored tablets with "dp" embossed on one side and "30" on the other side of the tablet.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


 

MEMBERS CAN ACCESS MONEY SAVING BENEFITS BY Cicking Here